Back
Amphastar Pharmaceuticals 10K Form
Sell
43
AMPH
Amphastar Pharmaceuticals
Last Price:
40.03
Seasonality Move:
13.28%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AMPH News And Ratings
See the #1 stock for the next 7 days that we like better than AMPH
AMPH Financial Statistics
Sales & Book Value
Annual Sales: | $644.4M |
---|---|
Cash Flow: | $14.42M |
Price / Cash Flow: | 14.09 |
Annual Sales: | $13.30 |
Price / Book: | 2.91 |
Profitability
EPS (TTM): | 2.58000 |
---|---|
Net Income (TTM): | $137.55M |
Gross Margin: | $351.12M |
Return on Equity: | 23.71% |
Return on Assets: | 11.56% |
Amphastar Pharmaceuticals Earnings Forecast
Key Amphastar Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 21 years for AMPH is 54.49%.
- The Selling, General & Administrative Expenses for AMPH have been equal to 12.48% of Gross Profit Margin.
- The Research & Development expenses have been 11.44% of Revenue.
- The Interest Expense is 19.74% of Operating Income.
- The Net Earning history of AMPH is 21.34% of Total Revenues.
- Per Share Earnings over the last 21 years have been positive in 10 years.
Amphastar Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | AMPH |
CUSIP: | 03209R |
Website: | amphastar.com |
Debt
Debt-to-Equity Ratio: | 0.92 |
---|---|
Current Ratio: | 2.17 |
Quick Ratio: | 1.65 |
Price-to-Earnings
Trailing P/E Ratio: | 14.86 |
---|---|
Forward P/E Ratio: | 9.08 |
AMPH Technical Analysis vs Fundamental Analysis
Sell
43
Amphastar Pharmaceuticals (AMPH)
is a Sell
Is Amphastar Pharmaceuticals a Buy or a Sell?
-
Amphastar Pharmaceuticals stock is rated a Sell
The current Amphastar Pharmaceuticals [AMPH] share price is $38.63. The Score for AMPH is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.